{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:18:47Z","timestamp":1794651527463,"version":"4.9.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"48","license":[{"start":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T00:00:00Z","timestamp":1638489600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Hepatic nodular regenerative hyperplasia (NRH), a nonspecific change in the liver parenchyma, is very rare in children. Hepatic microvascular changes may be the cause, as these vascular changes are uncommon in children. Antiphospholipid syndrome (APS), an autoimmune disease characterized by vascular thromboembolism, is extremely unusual in children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 13-year-old girl who presented with abdominal pain and elevated liver enzymes was transferred to our hospital. Abdominal computed tomography and magnetic resonance imaging showed a massive mesenteric venous thrombus and a malignant mass with liver metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Her immunological profile was positive for antinuclear antibodies (ANA) at a titer of 1\/160 (nucleolar pattern), anticardiolipin antibodies (aCL) immunoglobulin G, and anti-histone antibody. A liver biopsy revealed hepatic NRH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient was initially started on heparin upon hospitalization and switched to warfarin and a vitamin K antagonist and continued treatment with international normalized ratio monitoring.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Her symptoms improved after 9 months of anticoagulation therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>In the presence of hepatic NRH or vascular thrombosis in children, we recommend that APS be differentially diagnosed using lupus anticoagulant and aCL and appropriate management be implemented.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000028105","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T08:19:28Z","timestamp":1638519568000},"page":"e28105","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Antiphospholipid syndrome with mesenteric vein thrombosis and hepatic nodular regenerative hyperplasia in a child"],"prefix":"10.1097","volume":"100","author":[{"given":"Seung Hyung","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Duk","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5947-4599","authenticated-orcid":false,"given":"Soon Chul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12,3]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3748\/wjg.v17.i11.1400","article-title":"Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension","volume":"17","author":"Hartleb","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jaut.2014.01.006","article-title":"Diagnosis and classification of the antiphospholipid syndrome","volume":"48","author":"G\u00f3mez-Puerta","year":"2014","journal-title":"J Autoimmun"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1093\/rheumatology\/kem158","article-title":"The abdominal manifestations of the antiphospholipid syndrome","volume":"46","author":"Uthaman","year":"2007","journal-title":"Rheumatology"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1046\/j.1440-1746.2000.2354.x","article-title":"Focal nodular hyperplasia of the liver: direct evidence of circulatory disturbances","volume":"15","author":"Kumagai","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1136\/gut.2006.114363","article-title":"Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine","volume":"56","author":"Vernier-Massouille","year":"2007","journal-title":"Gut"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jhep.2013.08.013","article-title":"Non-cirrhotic portal hypertension: diagnosis and management","volume":"60","author":"Khanna","year":"2014","journal-title":"J Hepatol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/hep.30905","article-title":"Nodular regenerative hyperplasia associated with primary liver malignancies","volume":"71","author":"Penrice","year":"2020","journal-title":"Hepatology"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2468-1253(19)30047-0","article-title":"Porto-sinusoidal vascular disease: proposal and description of a novel entity","volume":"4","author":"De Gottardi","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"152833","DOI":"10.1016\/j.prp.2020.152833","article-title":"Nodular regenerative hyperplasia: an under-recognized vascular disorder of liver","volume":"216","author":"Bakshi","year":"2020","journal-title":"Pathol Res Pract"},{"key":"R10-20250504","first-page":"139","article-title":"Nodular regenerative hyperplasia of the liver associated with systemic lupus erythematosus; three cases","volume":"15","author":"Leung","year":"2009","journal-title":"Hong Kong Med J"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jpeds.2013.10.025","article-title":"Hospital-associated venous thromboembolism in children: incidence and clinical characteristics","volume":"164","author":"Takemoto","year":"2014","journal-title":"J Pediatr"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood.2019001847","article-title":"Treatment of venous thromboembolism in pediatric patients","volume":"135","author":"Witmer","year":"2020","journal-title":"Blood"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1182\/asheducation-2018.1.399","article-title":"Management of thrombosis in children and neonates: practical use of anticoagulants in children","volume":"2018","author":"Monagle","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/17474086.2018.1407241","article-title":"Duration of anticoagulant therapy in pediatric venous thromboembolism: current approaches and updates from randomized controlled trials","volume":"11","author":"Tarango","year":"2018","journal-title":"Expert Rev Hematol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1053\/jpsu.2000.8718","article-title":"Mesecteric vascular occlusion resulting in intestinal necrosis in children","volume":"35","author":"Oguzkurt","year":"2000","journal-title":"J Pediatr Surg"},{"issue":"(Suppl 1)","key":"R16-20250504","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0049-3848(17)30066-X","article-title":"Antiphospholipid syndrome","volume":"151","author":"Cervera","year":"2017","journal-title":"Thromb Res"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1182\/blood-2011-03-340232","article-title":"Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study","volume":"118","author":"Pengo","year":"2011","journal-title":"Blood"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/0961203310395803","article-title":"Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies","volume":"20","author":"Ruiz-Irastorza","year":"2011","journal-title":"Lupus"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:38:04Z","timestamp":1746319084000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028105"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2021,12,3]]},"references-count":19,"journal-issue":{"issue":"48","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028105","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,3]]},"assertion":[{"value":"2021-10-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}